Literature DB >> 8404980

Vancomycin intoxication in a preterm neonate.

W J Tissing, M A Umans-Eckenhausen, J N van den Anker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404980     DOI: 10.1007/bf01955255

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

Review 1.  Vancomycin- and erythromycin-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

2.  Vancomycin/aminoglycoside nephrotoxicity.

Authors:  R P Dean; D J Wagner; M D Tolpin
Journal:  J Pediatr       Date:  1985-05       Impact factor: 4.406

3.  Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four children.

Authors:  C Odio; G H McCracken; J D Nelson
Journal:  J Pediatr       Date:  1984-09       Impact factor: 4.406

4.  Clinical pharmacology and efficacy of vancomycin in pediatric patients.

Authors:  U B Schaad; G H McCracken; J D Nelson
Journal:  J Pediatr       Date:  1980-01       Impact factor: 4.406

Review 5.  Vancomycin ototoxicity and nephrotoxicity. A review.

Authors:  G R Bailie; D Neal
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct
  5 in total
  3 in total

Review 1.  Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.

Authors:  K A Rodvold; J A Everett; R D Pryka; D M Kraus
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

2.  Vancomycin intoxications in preterm infants.

Authors:  J C Möller; G Nachtrodt; L Gortner
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

Review 3.  Vancomycin: pharmacokinetics and administration regimens in neonates.

Authors:  Matthijs de Hoog; Johan W Mouton; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.